Intermediate Hepatobiliary Cells Predict an Increased Risk of Hepatocarcinogenesis in Patients With Hepatitis C Virus-Related Cirrhosis

Gastroenterology

Volumn 139, Issue 1, 2010, Pages

  Ziol, Marianne ^a   Nault, Jean Charles ^a   Aout, Mounir ^b   Barget, Nathalie ^a   Tepper, Maryline ^a   Martin, Antoine ^c   Trinchet, Jean Claude ^a   Ganne Carrié, Nathalie ^a   Vicaut, Eric ^b   Beaugrand, Michel ^a   N'Kontchou, Gisele ^a  

^a HÔPITAL JEAN VERDIER   (France)

^b HÔPITAL FERNAND WIDAL   (France)

^c AVICENNE HOSPITAL   (France)

Author keywords

Cancer Stem Cells; HCV Related Cirrhosis; Hepatocellular Carcinoma; Intermediate Hepatobiliary Cells

Indexed keywords

CYTOKERATIN 7; EPITHELIAL CELL ADHESION MOLECULE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER STEM CELL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMEDIATE HEPATOBILIARY CELL; LIVER BIOPSY; LIVER CARCINOGENESIS; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 77954045897     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2010.04.012     Document Type: Article

References (43)

1. Camma C., Giunta M., Andreone P., et al. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach. J Hepatol 34 (2001) 593-602
2. El-Serag H.B., Marrero J.A., Rudolph L., et al. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134 (2008) 1752-1763
3. Degos F., Christidis C., Ganne-Carrie N., et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 47 (2000) 131-136
4. N'Kontchou G., Paries J., Htar M.T., et al. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis. Clin Gastroenterol Hepatol 4 (2003) 1062-1068
5. Rodríguez-Díaz J.L., Rosas-Camargo V., Vega-Vega O., et al. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study. Clin Oncol 19 (2007) 197-203
6. Pekow J.R., Bhan A.K., Zheng H., et al. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 109 (2007) 2490-2496
7. Ganne-Carrié N., Chastang C., Chapel F., et al. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis. Hepatology 23 (1996) 1112-1118
8. Donato M.F., Arosio E., Del Ninno E., et al. High rates of hepatocellular carcinoma in cirrhotic patients with high liver cell proliferative activity. Hepatology 34 (2001) 523-528
9. Roskams T.A., Theise N.D., Balabaud C., et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 39 (2004) 1739-1745
10. Thorgeirsson S.S., Factor V.M., and Snyderwine E.G. Transgenic mouse models in carcinogenesis research and testing. Toxicol Lett 15 (2000) 553-555
11. Libbrecht L., Meerman L., Kuipers F., et al. Liver pathology and hepatocarcinogenesis in a long-term mouse model of erythropoietic protoporphyria. J Pathol 199 (2003) 191-200
12. Cerec V., Glaise D., Garnier D., et al. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 45 (2007) 957-967
13. Ma S., Chan K.W., Hu L., et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology 132 (2007) 2542-2556
14. Roskams T. Different types of liver progenitor cells and their niches. J Hepatol 45 (2006) 1-4
15. Mallet V., Gilgenkrantz H., Serpaggi J., et al. Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C. Ann Intern Med 149 (2008) 399-403
16. Bruix J., Sherman M., Llovet J., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. J Hepatol 35 (2001) 421-430
17. Watanabe S., Okita K., Harada T., et al. Morphologic studies of the liver cell dysplasia. Cancer 51 (1983) 2197-2205
18. The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 20 (1994) 15-20
19. Fine J.P., and Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94 (1999) 496-509
20. Gray R.J. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 16 (1988) 1140-1154
21. Crosby H.A., Hubscher S., Fabris L., et al. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am J Pathol 152 (1998) 771-779
22. Marchio A., Terris B., Meddeb M., et al. Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation. Mol Pathol 54 (2001) 270-274
23. Adachi E., Hashimoto H., and Tsuneyoshi M. Proliferating cell nuclear antigen in hepatocellular carcinoma and small cell liver dysplasia. Cancer 72 (1993) 2902-2909
24. Libbrecht L., Craninx M., Nevens F., et al. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis. Histopathology 39 (2001) 66-73
25. Brunt E.M., Walsh S.N., Hayashi P.H., et al. Hepatocyte senescence in end-stage chronic liver disease: a study of cyclin-dependent kinase inhibitor p21 in liver biopsies as a marker for progression to hepatocellular carcinoma. Liver Int 27 (2007) 662-671
26. Makino Y., Shiraki K., Sugimoto K., et al. Histological features of cirrhosis with hepatitis C virus for prediction of hepatocellular carcinoma development; a prospective study. Anticancer Res 20 (2000) 3709-3715
27. Libbrecht L., Desmet V., Van Damme B., et al. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J Hepatol 33 (2000) 76-84
28. Hoshida Y., Villanueva A., Kobayashi M., et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N Engl J Med 359 (2008) 1995-2004
29. Roskams T., Yang S.Q., Koteish A., et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. Am J Pathol 163 (2003) 1301-1311
30. Clouston A.D., Powell E.E., Walsh M.J., et al. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 4 (2005) 809-918
31. Marongiu F., Doratiotto S., Montisci S., et al. Liver repopulation and carcinogenesis: two sides of the same coin?. Am J Pathol 172 (2008) 857-864
32. Durnez A., Verslype C., Nevens F., et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 49 (2006) 138-151
33. Terris B., Ingster O., Rubbia L., et al. Interphase cytogenetic analysis reveals numerical chromosome aberrations in large liver cell dysplasia. J Hepatol 27 (1997) 313-319
34. Yamashita T., Ji J., Budhu A., et al. EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features. Gastroenterology 136 (2009) 1012-1024
35. Lackner C., Gogg-Kamerer M., Zatloukal K., et al. Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. J Hepatol 48 (2008) 821-828
36. Xiao J.C., Jin X.L., Ruck P., et al. Hepatic progenitor cells in human liver cirrhosis: immunohistochemical, electron microscopic and immunofluorescence confocal microscopic findings. World J Gastroenterol 10 (2004) 1208-1211
37. Crosby H.A., Hubscher S., Fabris L., et al. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6. Am J Pathol 152 (1998) 771-779
38. Michalopoulos G.K., Barua L., and Bowen W.C. Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury. Hepatology 41 (2005) 535-544
39. Cerec V., Glaise D., Garnier D., et al. Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor. Hepatology 45 (2007) 957-967
40. Mishra L., Banker T., Murray J., et al. Liver stem cells and hepatocellular carcinoma. Hepatology 49 (2009) 318-329
41. Fattovich G., Stroffolini T., Zagni I., et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 (2004) S35-S50
42. Serfaty L., Aumaître H., Chazouillères O., et al. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 27 (1998) 1435-1440
43. Sangiovanni A., Prati G.M., Fasani P., et al. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 43 (2006) 1303-1310